Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

Alzheimer's and Dementia

Volumn 10, Issue 1, 2014, Pages 53-61

  Rembach, Alan ^a   Faux, Noel G ^a   Watt, Andrew D ^a   Pertile, Kelly K ^a   Rumble, Rebecca L ^a   Trounson, Brett O ^a   Fowler, Christopher J ^a   Roberts, Blaine R ^a   Perez, Keyla A ^a   Li, Qiao Xin ^a   Laws, Simon M ^b,c   Taddei, Kevin ^b,c   Rainey Smith, Stephanie ^b,c   Robertson, Joanne S ^a   Vandijck, Manu ^d   Vanderstichele, Hugo ^d,e   Barnham, Kevin J ^a   Ellis, Kathryn A ^a,h   Szoeke, Cassandra ^a,h   MacAulay, Lance ^f   Rowe, Christopher C ^g   Villemagne, Victor L ^a,g   Ames, David ^h   Martins, Ralph N ^b,c   Bush, Ashley I ^a   Masters, Colin L ^a   more..

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HOLLYWOOD PRIVATE HOSPITAL   (Australia)

^c EDITH COWAN UNIVERSITY   (Australia)

^d Innogenetics NV ^*  (Belgium)

^e Biomarkable   (Belgium)

^f CSIRO   (Australia)

^g AUSTIN HEALTH   (Australia)

^h NATIONAL AGEING RESEARCH INSTITUTE   (Australia)

Author keywords

Alzheimer's disease; Amyloid ; Biomarkers; Diagnosis; Pittsburgh compound B; Positron emission tomography

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[N-40]; AMYLOID BETA PROTEIN[N-42]; PITTSBURGH COMPOUND B; UNCLASSIFIED DRUG;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISODIC MEMORY; EXECUTIVE FUNCTION; FEMALE; FOLLOW UP; HUMAN; KIDNEY FUNCTION; KRUSKAL WALLIS TEST; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

ALZHEIMER'S DISEASE; AMYLOID-Β; BIOMARKERS; DIAGNOSIS; PITTSBURGH COMPOUND B; POSITRON EMISSION TOMOGRAPHY;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEIN E4; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; POSITRON-EMISSION TOMOGRAPHY;

EID: 84891163157     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.12.006     Document Type: Article

References (28)

1. D.J. Selkoe Resolving controversies on the path to Alzheimer's therapeutics Nat Med 17 2011 1060 1065
2. C. Haass, and D.J. Selkoe Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide Nat Rev Mol Cell Biol 8 2007 101 112 (Pubitemid 46432529)
3. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 2010 131 144
4. F. Song, A. Poljak, M. Valenzuela, R. Mayeux, G.A. Smythe, and P.S. Sachdev Meta-analysis of plasma amyloid-beta levels in Alzheimer's disease J Alzheimers Dis 26 2011 365 375
5. A. Koyama, O.I. Okereke, T. Yang, D. Blacker, D.J. Selkoe, and F. Grodstein Plasma amyloid-beta as a predictor of dementia and cognitive decline: a systematic review and meta-analysis Arch Neurol 69 2012 824 831
6. M.C. Irizarry Biomarkers of Alzheimer disease in plasma NeuroRx J Am Soc Exp Neurotherapeutics 1 2004 226 234 (Pubitemid 46591884)
7. T. Sobow, M. Flirski, I. Kloszewska, and P.P. Liberski Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease Acta Neurobiol Exp (Warsaw) 65 2005 117 124 (Pubitemid 40874206)
8. O. Hansson, H. Zetterberg, E. Vanmechelen, H. Vanderstichele, U. Andreasson, and E. Londos et al. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment Neurobiol Aging 31 2010 357 367
9. J. Sundelof, V. Giedraitis, M.C. Irizarry, J. Sundstrom, E. Ingelsson, and E. Ronnemaa et al. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study Arch Neurol 65 2008 256 263 (Pubitemid 351240790)
10. S.A. Cosentino, Y. Stern, E. Sokolov, N. Scarmeas, J.J. Manly, and M.X. Tang et al. Plasma ss-amyloid and cognitive decline Arch Neurol 67 2010 1485 1490
11. C. Laske, K. Sopova, C. Gkotsis, G.W. Eschweiler, G. Straten, and M. Gawaz et al. Amyloid-beta peptides in plasma and cognitive decline after 1 year follow-up in Alzheimer's disease patients J Alzheimers Dis 21 2010 1263 1269
12. R. Mayeux, L.S. Honig, M.X. Tang, J. Manly, Y. Stern, and N. Schupf et al. Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk Neurology 61 2003 1185 1190 (Pubitemid 37377535)
13. M. Pesaresi, C. Lovati, P. Bertora, E. Mailland, D. Galimberti, and E. Scarpini et al. Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment Neurobiol Aging 27 2006 904 905 (Pubitemid 44287903)
14. J.K. Lui, S.M. Laws, Q.X. Li, V.L. Villemagne, D. Ames, and B. Brown et al. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging J Alzheimers Dis 20 2010 1233 1242
15. N.R. Graff-Radford, J.E. Crook, J. Lucas, B.F. Boeve, D.S. Knopman, and R.J. Ivnik et al. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease Arch Neurol 64 2007 354 362 (Pubitemid 46425689)
16. K. Blennow, G. De Meyer, O. Hansson, L. Minthon, A. Wallin, and H. Zetterberg et al. Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessment J Nutr Health Aging 13 2009 205 208
17. K. Yaffe, A. Weston, N.R. Graff-Radford, S. Satterfield, E.M. Simonsick, and S.G. Younkin et al. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline JAMA 305 2011 261 266
18. R. Mayeux, M.X. Tang, D.M. Jacobs, J. Manly, K. Bell, and C. Merchant et al. Plasma amyloid beta-peptide 1-42 and incipient Alzheimer's disease Ann Neurol 46 1999 412 416 (Pubitemid 29416281)
19. J.B. Toledo, H. Vanderstichele, M. Figurski, P.S. Aisen, R.C. Petersen, and M.W. Weiner et al. Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI Acta Neuropathol 122 2011 401 413
20. K.A. Ellis, A.I. Bush, D. Darby, D. De Fazio, J. Foster, and P. Hudson et al. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease Int Psychogeriatr 21 2009 672 687
21. C.C. Rowe, S. Ng, U. Ackermann, S.J. Gong, K. Pike, and G. Savage et al. Imaging beta-amyloid burden in aging and dementia Neurology 68 2007 1718 1725 (Pubitemid 46763260)
22. K.G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, and J.C. Morris et al. Decreased clearance of CNS beta-amyloid in Alzheimer's disease Science 330 2010 1774
23. M.J. Figurski, T. Waligorska, J. Toledo, H. Vanderstichele, M. Korecka, and V.M. Lee et al. Improved protocol for measurement of plasma beta-amyloid in longitudinal evaluation of Alzheimer's Disease Neuroimaging Initiative study patients Alzheimers Dement 8 2012 250 260
24. E. Fukumoto, H. Sakai, S. Fukumoto, T. Yagi, O. Takagi, and Y. Kato Cadherin-related neuronal receptors in incisor development J Dent Res 82 2003 17 22
25. Z. Arvanitakis, J.A. Lucas, L.H. Younkin, S.G. Younkin, and N.R. Graff-Radford Serum creatinine levels correlate with plasma amyloid beta protein Alzheimer Dis Assoc Disord 16 2002 187 190 (Pubitemid 35001095)
26. L.H. Kuller, W.T. Longstreth Jr., A.M. Arnold, C. Bernick, R.N. Bryan, and N.J. Beauchamp Jr. White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke Stroke 35 2004 1821 1825 (Pubitemid 38971858)
27. O.L. Lopez, L.H. Kuller, P.D. Mehta, J.T. Becker, H.M. Gach, and R.A. Sweet et al. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study Neurology 70 2008 1664 1671 (Pubitemid 351644132)
28. H. Fukumoto, M. Tennis, J.J. Locascio, B.T. Hyman, J.H. Growdon, and M.C. Irizarry Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels Arch Neurol 60 2003 958 964 (Pubitemid 36858355)